Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 243.78 USD 0.01% Market Closed
Market Cap: 35.8B USD
Have any thoughts about
Resmed Inc?
Write Note

Gross Margin
Resmed Inc

57.7%
Current
56%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.7%
=
Gross Profit
2.8B
/
Revenue
4.8B

Gross Margin Across Competitors

Country US
Market Cap 35.8B USD
Gross Margin
58%
Country US
Market Cap 204.9B USD
Gross Margin
56%
Country US
Market Cap 195.2B USD
Gross Margin
67%
Country US
Market Cap 146.7B USD
Gross Margin
64%
Country US
Market Cap 132.6B USD
Gross Margin
69%
Country IE
Market Cap 110.6B USD
Gross Margin
66%
Country US
Market Cap 64.7B USD
Gross Margin
45%
Country DE
Market Cap 55.6B EUR
Gross Margin
38%
Country CN
Market Cap 319.2B CNY
Gross Margin
65%
Country US
Market Cap 41.6B USD
Gross Margin
79%
Country US
Market Cap 37.7B USD
Gross Margin
41%
No Stocks Found

Resmed Inc
Glance View

Market Cap
35.8B USD
Industry
Health Care

ResMed Inc. is a leading global company dedicated to transforming the lives of individuals suffering from sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Founded in 1989, ResMed has consistently innovated in the development of cutting-edge devices and cloud-connected software that enable patients to monitor their health and improve their quality of life. The company’s flagship products, including CPAP machines and adaptive cloud-based solutions, make it easier for patients to adhere to therapy while providing valuable data to healthcare providers. This commitment to integrating technology with healthcare has positioned ResMed as a key player in the booming health tech industry, appealing to both patients and investors alike. As the demand for effective respiratory therapy solutions continues to grow, driven by rising incidences of sleep disorders and an aging global population, ResMed stands out with its strong market presence and strategic focus on digital health. The company's agile approach allows it to swiftly adapt to changing market dynamics, evidenced by its expansion into software solutions that enhance patient management and clinical outcomes. With a robust balance sheet and a commitment to sustainable growth, ResMed not only offers potential for solid long-term returns but also embodies the principles of value investing that resonate with discerning investors. As the landscape of healthcare evolves, ResMed is poised to remain at the forefront, making it a compelling option for those looking to invest in the future of health technology.

RMD Intrinsic Value
192.96 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.7%
=
Gross Profit
2.8B
/
Revenue
4.8B
What is the Gross Margin of Resmed Inc?

Based on Resmed Inc's most recent financial statements, the company has Gross Margin of 57.7%.